(Q44528110)

3 December 2017

title

Aberrant promoter methylation of the cadherin 13 gene in serum and its relationship with clinicopathological features of prostate cancer (English)

1 reference

3 December 2017

Li Wang

1

1 reference

3 December 2017

Ying-Li Lin

2

1 reference

3 December 2017

Bo Li

3

1 reference

3 December 2017

Yu-Zhong Wang

4

1 reference

3 December 2017

Wen-Ping Li

5

1 reference

3 December 2017

Jian-Guo Ma

6

1 reference

3 December 2017

publication date

11 July 2014

1 reference

Journal of International Medical Research

3 December 2017

published in

1 reference

3 December 2017

volume

42

1 reference

3 December 2017

issue

5

1 reference

3 December 2017

page(s)

1085-1092

1 reference

3 December 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Current approaches, challenges and future directions for monitoring treatment response in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Aberrant DNA methylation and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Methylation markers for prostate cancer prognosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Epigenetic regulation of MDR1 gene through post-translational histone modifications in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Downregulation of CDH13 expression promotes invasiveness of bladder transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Methylated genes as potential biomarkers in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Promoter methylation of H-cadherin is a potential biomarker in patients with bladder transitional cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Epigenetic reprogramming in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

DNA methylation changes in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

Effect of DNA methylation on identification of aggressive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0300060514540631

21 January 2018

Identifiers

DOI

10.1177/0300060514540631

1 reference

3 December 2017

1 reference